Abstract
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1136/bmjebm-2024-113101
Copy DOIJournal: BMJ Evidence-Based Medicine | Publication Date: Jan 7, 2025 |
License type: CC BY 4.0 |
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.